Trademark Overview
On Friday, January 9, 2026, a trademark application was filed for GLOMTHERA with the United States Patent and Trademark Office. The USPTO has given the GLOMTHERA trademark a serial number of 79445697. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, March 12, 2026. This trademark is owned by Purespring Therapeutics Limited. The GLOMTHERA trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical, medical and scientific research; providing scientific research information; research in the field of gene therapy; services for assessing the efficiency of pharmaceutical and medical preparations and substances; clinical trials; pharmaceutical and biopharmaceutical drug development services; research, and development of pharmaceutical preparations for gene therapy; biotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research and development regarding the use of screening platforms to discover, research and develop novel capsids for genetic delivery of gene therapies and pharmaceuticals; research and development regarding the identification and targeting of specific cells and tissues for gene therapy delivery; providing medical and scientific research information on the prevention, diagnosis, and treatment of kidney diseases; providing a website featuring medical information and medical...
Pharmaceutical, medical and veterinary preparations and substances for the prevention, diagnosis and treatment of kidney diseases; reagents for use in medical genetic testing; biological, chemical and biochemical reagents for medical use; gene therapy products for medical and veterinary use; medical and veterinary preparations containing therapeutic DNA and RNA; biological, chemical, and biochemical reagents for medical purposes; pharmaceutical preparations, biological preparations, and gene therapy products for medical or pharmaceutical purposes, including, gene therapies, viral vectors, and nucleic-acid delivery products for use in the treatment of kidney diseases and disorders; pharmaceutical preparations for use in gene therapy; viral vectors for use in the delivery of gene therapy; adeno-associated virus (AAV) gene therapy; drug delivery agents consisting of capsids that facilitate delivery of pharmaceuticals and biopharmaceuticals; vaccines.
Pharmaceutical and medical services; medical diagnostic and screening services; health care services; advisory services in the fields of medicine and pharmacology; consultancy and information services relating to pharmaceutical and medical preparations and substances; medical diagnosis and treatment of kidney diseases; medical testing, analysis, reporting, assessment and monitoring services relating to the treatment and management of kidney diseases; pharmaceutical and medical information.
